Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency
dc.contributor.author | Taylor, J. R. | en_US |
dc.contributor.author | Gardner, T. B. | en_US |
dc.contributor.author | Waljee, Akbar K. | en_US |
dc.contributor.author | Dimagno, M. J. | en_US |
dc.contributor.author | Schoenfeld, Philip S. | en_US |
dc.date.accessioned | 2010-06-01T18:38:29Z | |
dc.date.available | 2010-06-01T18:38:29Z | |
dc.date.issued | 2010-01 | en_US |
dc.identifier.citation | TAYLOR, J. R.; GARDNER, T. B.; WALJEE, A. K.; DIMAGNO, M. J.; SCHOENFELD, P. S. (2010). "Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency." Alimentary Pharmacology & Therapeutics 31(1): 57-72. <http://hdl.handle.net/2027.42/71842> | en_US |
dc.identifier.issn | 0269-2813 | en_US |
dc.identifier.issn | 1365-2036 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71842 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19804466&dopt=citation | en_US |
dc.format.extent | 144401 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Journal compilation © 2010 Blackwell Publishing Ltd | en_US |
dc.title | Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | † Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH | en_US |
dc.contributor.affiliationother | † VA Center for Excellence in Health Sciences Research, Ann Arbor, MI | en_US |
dc.identifier.pmid | 19804466 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71842/1/j.1365-2036.2009.04157.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2036.2009.04157.x | en_US |
dc.identifier.source | Alimentary Pharmacology & Therapeutics | en_US |
dc.identifier.citedreference | 1 Federal Register cited (69 82); Docket No. 2003N-0205. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/04-9652.htm (accessed 25 October 2009). | en_US |
dc.identifier.citedreference | Waljee AK, Dimagno MJ, Wu BU, Schoenfeld PS, Conwell DL. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther 2009; 29: 235 – 46. | en_US |
dc.identifier.citedreference | Francisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 79 – 83. | en_US |
dc.identifier.citedreference | Borowitz D, Konstan MW, O'Rourke A, Cohen M, Hendeles L, Murray FT. Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. J Pediatr Pharmacol Ther 2007; 12: 47 – 52. | en_US |
dc.identifier.citedreference | Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1 – 12. | en_US |
dc.identifier.citedreference | Armbrecht U, Svanvik J, StockbrÜgger R. Enzyme substitution in chronic pancreatitis: effects on clinical and functional parameters and on the hydrogen (H2) breath test. Scand J Gastroenterol Suppl 1986; 126: 55 – 9. | en_US |
dc.identifier.citedreference | Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 1987; 62: 564 – 8. | en_US |
dc.identifier.citedreference | Brady MS, Garson JL, Krug SK, et al. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. J Am Diet Assoc 2006; 106: 1181 – 6. | en_US |
dc.identifier.citedreference | Gullo L, Pezzilli A, Cassano A, Ligabue A, Ventrucci M. Clinical effectiveness of a new enteric-coated pancreatic enzyme extract in the treatment of pancreatic steatorrhea. Curr Ther Res 1988; 44: 105 – 9. | en_US |
dc.identifier.citedreference | Halgreen H, Pedersen NT, Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 1986; 21: 104 – 8. | en_US |
dc.identifier.citedreference | Marotta F, Girdwood AH, Marks IN, O’Keefe SJD, Young GO. Enteric-coated pancreatic enzyme supplementation. A dose-response study. Pathophysiology 1995; 2: 247 – 50. | en_US |
dc.identifier.citedreference | Mischler EH, Parrell S, Farrell PM, Odell GB. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child 1982; 136: 1060 – 3. | en_US |
dc.identifier.citedreference | Morrison G, Morrison JM, Redmond AO, et al. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther 1992; 6: 549 – 55. | en_US |
dc.identifier.citedreference | Opekun AR Jr, Sutton FM Jr, Graham DY. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults. Aliment Pharmacol Ther 1997; 11: 981 – 6. | en_US |
dc.identifier.citedreference | Paris JC. A multicentre double-blind placebo-controlled study of the effect of a pancreatic enzyme formulation (Panzytrat 25000) on impaired lipid digestion in adults with chronic pancreatitis. Drug Investig 1993; 5: 229 – 37. | en_US |
dc.identifier.citedreference | Pasquali C, Fogar P, Sperti C, Basso D. Efficacy of a pancreatic enzyme formulation in the treatment of steatorrhea in patients with chronic pancreatitis. Curr Ther Res 1996; 57: 358 – 65. | en_US |
dc.identifier.citedreference | Patchell CJ, Desai M, Weller PH, et al. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres – an open randomised crossover preference study. J Cyst Fibros 2002; 1: 287 – 91. | en_US |
dc.identifier.citedreference | Robinson PJ, Olinsky A, Smith AL, Chitravanshi SB. High compared with standard dose lipase pancreatic supplement. Arch Dis Child 1989; 64: 143 – 5. | en_US |
dc.identifier.citedreference | Shah A, Dinwiddie R, Madge S, Prescott P, Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr 1993; 152: 763 – 4. | en_US |
dc.identifier.citedreference | Thomson M, Clague A, Cleghorn GJ, Shepherd RW. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1993; 17: 407 – 13. | en_US |
dc.identifier.citedreference | Vantini I, Fioretta A, Caliari S, Benini L, Brentegani MT, Castellani G. Effects of two pancreatic enzyme-containing enteric-coated microsphere preparations on steatorrhea in chronic alcoholic pancreatitis. Curr Ther Res 1990; 48: 268 – 74. | en_US |
dc.identifier.citedreference | Vyas H, Matthew DJ, Milla PJ. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Eur J Pediatr 1990; 149: 241 – 3. | en_US |
dc.identifier.citedreference | Bowler IM, Wolfe SP, Owens HM, Sheldon TA, Littlewood JM, Walters MP. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child 1993; 68: 227 – 30. | en_US |
dc.identifier.citedreference | Delchier JC, Vidon N, Saint-Marc Girardin MF, et al. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations. Aliment Pharmacol Ther 1991; 5: 365 – 78. | en_US |
dc.identifier.citedreference | Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8: 699 – 703. | en_US |
dc.identifier.citedreference | Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983; 84: 476 – 82. | en_US |
dc.identifier.citedreference | Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Aliment Pharmacol Ther 1994; 8: 603 – 7. | en_US |
dc.identifier.citedreference | Gouerou H, Dain MP, Parrondo I, Poisson D, Bernades P. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study. Int J Pancreatol 1989; 5: 45 – 50. | en_US |
dc.identifier.citedreference | Halm U, Loser C, Lohr M, Katschinski M, Mossner J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther 1999; 13: 951 – 7. | en_US |
dc.identifier.citedreference | Kalnins D, Ellis L, Corey M, et al. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006; 42: 256 – 61. | en_US |
dc.identifier.citedreference | Konstan MW, Stern RC, Trout JR, et al. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy. Aliment Pharmacol Ther 2004; 20: 1365 – 71. | en_US |
dc.identifier.citedreference | Lancellotti L, Cabrini G, Zanolla L, Mastella G. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial. J Pediatr Gastroenterol Nutr 1996; 22: 73 – 8. | en_US |
dc.identifier.citedreference | Santini B, Antonelli M, Battistini A, et al. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Dig Liver Dis 2000; 32: 406 – 11. | en_US |
dc.identifier.citedreference | Williams J, MacDonald A, Weller PH, Fields J, Pandov H. Two enteric coated microspheres in cystic fibrosis. Arch Dis Child 1990; 65: 594 – 7. | en_US |
dc.identifier.citedreference | DiMagno EP. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Best Pract Res Clin Gastroenterol 2001; 15: 477 – 86. | en_US |
dc.identifier.citedreference | Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156 – 62. | en_US |
dc.identifier.citedreference | Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169: 1035 – 45. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.